10월
21
2022
Blow To Roche’s Cancer Immunotherapy Prospects As 2nd Trial Fails
Beating out US-based Pfizer to the quantity a single spot this year, Roche counted an 8.3 % raise in sales revenues over the last year. Reinvesting...
hoffmannla
Beating out US-based Pfizer to the quantity a single spot this year, Roche counted an 8.3 % raise in sales revenues over the last year. Reinvesting...